Trial · NCT02494141
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change in Brachial Artery Flow-mediated Dilation (FMD-BA) | Curcumin | 1.14 | 95% Confidence Interval -0.84 to 3.13 | percent change | |
| Percent Change in Brachial Artery Flow-mediated Dilation (FMD-BA) | Placebo | 0.3 | 95% Confidence Interval -1.34 to 2.00 | percent change | |
| Change in Aortic Pulse-wave Velocity (aPWV) (cm/Sec) | Curcumin | 0.6 | 95% Confidence Interval -25.7 to 26.9 | cm/sec | |
| Change in Aortic Pulse-wave Velocity (aPWV) (cm/Sec) | Placebo | 6.5 | 95% Confidence Interval -20.4 to 33.5 | cm/sec | |
| Change in Urinary 8-iso-prostaglandin F2α (8-isoprostane) | Curcumin | 0.00 | 95% Confidence Interval -0.34 to 0.34 | mg/dl | |
| Change in Urinary 8-iso-prostaglandin F2α (8-isoprostane) | Placebo | 0.27 | 95% Confidence Interval -0.14 to 0.69 | mg/dl | |
| Change in C-reactive Protein | Curcumin | 0.21 | 95% Confidence Interval -0.47 to 0.88 | mg/L | |
| Change in C-reactive Protein | Placebo | 0.17 | 95% Confidence Interval -0.36 to 0.70 | mg/L | |
| Change in Interleukin-6 | Curcumin | 2.24 | 95% Confidence Interval 1.69 to 2.80 | picograms/mL | |
| Change in Interleukin-6 | Placebo | 2.33 | 95% Confidence Interval 1.89 to 2.76 | picograms/mL | |
| Percent Change in Oxidative Stress-associated Suppression of Endothelium-dependent Dilation (EDD) | Curcumin | Baseline | 3.0 | Standard Deviation 0.95 | Percent change |
| Percent Change in Oxidative Stress-associated Suppression of Endothelium-dependent Dilation (EDD) | Placebo | Baseline | 1.7 | Standard Deviation 3.0 | Percent change |
| Percent Change in Oxidative Stress-associated Suppression of Endothelium-dependent Dilation (EDD) | Curcumin | Month 12 | 1.1 | Standard Deviation 3.5 | Percent change |
| Percent Change in Oxidative Stress-associated Suppression of Endothelium-dependent Dilation (EDD) | Placebo | Month 12 | 1.4 | Standard Deviation 2.6 | Percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02494141/results